Moneycontrol
HomeNewsBusinessCOVID-19 fallout: Rising bio-medical waste poses fresh challenge
Trending Topics

COVID-19 fallout: Rising bio-medical waste poses fresh challenge

The quantity of Bio-medical wastes generated per day in the country has almost doubled from 7.22 lakh kg before COVID to nearly 14 lakh kg now, according to the Indian Medical Association (IMA)

May 11, 2021 / 18:21 IST
Story continues below Advertisement

With the second wave of COVID-19 creating havoc in India, along with the rise in the number of cases, the country has an unlikely menace at hand - the rising pile of Bio-medical wastes.

The quantity of Bio-medical wastes generated per day in the country has almost doubled from 7.22 lakh kg in pre-Covid times to nearly 14 lakh kg now, according to the Indian Medical Association (IMA).

Story continues below Advertisement

J A Jayalal, president of the IMA, told Moneycontrol: “Overall Bio-medical wastes produced in the country would have almost doubled to around 13 to 14 lakh kg now. If you investigate generation of per-bed Bio-medical wastes, it may have increased to around 400 grams per day.”

Before the COVID outbreak, per-bed Bio-medical wastes were to the tune of 250 grams per day.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show